Amyris Inc. (AMRS)

3.61
NASDAQ : Process Industries
Prev Close 3.76
Day Low/High 3.58 / 3.84
52 Wk Low/High 1.87 / 8.13
Avg Volume 928.10K
Exchange NASDAQ
Shares Outstanding 103.40M
Market Cap 388.78M
EPS -3.70
P/E Ratio N/A
Div & Yield N.A. (N.A)
Short Interest Expands By 11.5% For AMRS

Short Interest Expands By 11.5% For AMRS

The most recent short interest data has been released by the NASDAQ for the 01/31/2014 settlement date, which shows a 643,936 share increase in total short interest for Amyris, Inc. , to 6,258,284, an increase of 11.47% since 01/15/2014.

Amyris Continues To Expand Sales Of Squalane In Asia

Amyris Continues To Expand Sales Of Squalane In Asia

Amyris Selects Dowell as Squalane Distributor in Korea to Meet Growing Demand for Best-in-Class Emollient

Amyris Meets Funding Milestones And Announces $28 Million Private Placement With Participation From New And Existing Investors

Amyris Meets Funding Milestones And Announces $28 Million Private Placement With Participation From New And Existing Investors

First Purpose-Built Industrial-Scale Plant Completes First Year of Successful Operation in Brazil

Amyris And TOTAL Form Fuels Joint Venture

Amyris And TOTAL Form Fuels Joint Venture

Total Amyris BioSolutions Established Produce and Commercialize Renewable Fuels From Amyris's Technology Platform

Amyris Announces Transition Of Chief Financial Officer

Amyris Announces Transition Of Chief Financial Officer

Paulo Diniz, Current President of Brazil Operations, to Become Amyris's CFO Upon Retirement of Steve Mills in December

Amyris Reports Third Quarter 2013 Financial Results

Amyris Reports Third Quarter 2013 Financial Results

Continued Strong Operational Performance and Lower Production Costs Lead to Another Strong Quarter for Amyris

Amyris To Enter Partnership To Supply Renewable Jet Fuel To GOL Airlines

Amyris To Enter Partnership To Supply Renewable Jet Fuel To GOL Airlines

Leading Airline in Brazil Seeks to Use Amyris's Sugarcane-Derived Jet Fuel Following Industry Validation and Regulatory Approvals

Amyris Meets Major Milestone At Its Farnesene Production Facility

Amyris Meets Major Milestone At Its Farnesene Production Facility

Amyris CEO to Speak at Advanced Biofuels Leadership Conference on Strong Performance of Amyris's Renewable Hydrocarbon Production in Brazil

Amyris Reports Second Quarter 2013 Financial Results

Amyris Reports Second Quarter 2013 Financial Results

Record Renewable Products Sales and Continued Progress at Farnesene Production Facility

Amyris Signs Agreement For Up To $60 Million In Funding From Temasek

Amyris Signs Agreement For Up To $60 Million In Funding From Temasek

Proceeds From Sale of Convertible Notes to Provide Financial Flexibility as Amyris Scales Up Production and Commercial Sales of Renewable Hydrocarbons

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors With Losses On Their Investment In Amyris, Inc. Of Class Action Lawsuit And The Deadline Of July 15, 2013 To Seek A Lead Plaintiff Position

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors With Losses On Their Investment In Amyris, Inc. Of Class Action Lawsuit And The Deadline Of July 15, 2013 To Seek A Lead Plaintiff Position

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of investors who purchased Amyris, Inc.

Commit To Purchase Amyris At $2.50, Earn 42.9% Annualized

Commit To Purchase Amyris At $2.50, Earn 42.9% Annualized

Investors considering a purchase of Amyris, Inc. shares, but tentative about paying the going market price of $2.78/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Amyris And Total Announce Successful Demonstration Flight With Renewable Jet Fuel During Paris Air Show

Amyris And Total Announce Successful Demonstration Flight With Renewable Jet Fuel During Paris Air Show

First Demonstration Flight in Europe on Airbus Aircraft Underscores Partners' Commitment to Achieving ASTM Certification

R. Neil Williams Joins Amyris Board Of Directors

R. Neil Williams Joins Amyris Board Of Directors

Patrick Pichette Steps Down but Will Remain a Strategic Advisor

Amyris Reports First Quarter 2013 Financial Results

Amyris Reports First Quarter 2013 Financial Results

Operating Expenses Down by 29% From the First Quarter of 2012, With Continued Revenue Improvement and Steady Business Execution

IFF And Amyris Announce A Multi-Year Collaboration To Develop And Commercialize Sustainable Ingredients For The Flavors And Fragrances Market

IFF And Amyris Announce A Multi-Year Collaboration To Develop And Commercialize Sustainable Ingredients For The Flavors And Fragrances Market

Amyris Breakthrough Industrial Biosynthesis Technology Platform to Reduce Supply Volatility of Critical Ingredients for the Aroma Industry

Amyris Selects Laserson As Squalane Distributor In Europe

Amyris Selects Laserson As Squalane Distributor In Europe

Laserson Brings In-Depth Experience in Squalane Distribution to European Cosmetics Market

Amyris Scientists Describe Breakthrough In Development Of Anti-Malarial Drug Precursor

Amyris Scientists Describe Breakthrough In Development Of Anti-Malarial Drug Precursor

Sanofi Utilizing Amyris Engineered Yeast Strains to Produce Life-Saving Drug Ingredient at Scale

Top Insider Trades: FES NLSN AGCO AMRS

Top Insider Trades: FES NLSN AGCO AMRS

The top 10 open-market insider purchases and sales filed at the SEC Friday.

Amyris Highlights Progress In Total And Cosan Partnerships

Amyris Highlights Progress In Total And Cosan Partnerships

Focused Execution Supported by Leading Partnerships and Investment Commitments

TheStreet Quant Rating: E+ (Sell)